Major Drugs - Ottawa, ON, CA
Member of the Board of Directors / Chief Operating Officer
Orion is a clinical stage company leveraging a proprietary technology platform to develop next generation therapeutics for effectively targeting G Protein-Coupled Receptors (GPCRs). Orion's platform enables effectively targeting previously undruggable complex GPCRs. Our pipeline includes 3 next generation therapeutics for cancer including our lead candidate - OB-002 – which is a first-in-class cancer immunotherapy with best-in-class potency.
Outlook
WordPress.org
Google Font API
Google Tag Manager
Mobile Friendly